PULMO-CAP, RAD Flashcards

1
Q

infection or inflammation affecting the parenchyma of the lung.

Histology- alveolitis with exudates in the alveolar space

5.6 million cases annually, 1.1 million hospitalizations
Avg. hospital mortality 12%,
1-2% mortality for outpatients

A

Community Acquired Pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SNF or hospitalized 90 days
Hospital visit or dialysis 30 days
Chemo, wound care, iv meds in 30 days
VAP (ventilator associated pneumonia)

A

HCAP (Health care associated pneumonia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathogenesis

A

o Direct inhalation of organisms

o Aspiration of oral contents

o deposits after hematogenous spread

o Direct penetration from a contiguous/contact site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical manifestations

A
Cough
fever
sputum production
chest pain
dyspnea

o May viral prodrome
o May onset with shaking chills
o May prodrome with malaise,
headache, dry cough, abdominal pain, nausea or diarrhea
o Elderly patients may have odd symptoms or no symptoms at all

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

• Physical findings

A

Tachypnea
tachycardia
o Signs of consolidation
o Crackles only or normal sounds, Local aveoli
o Other parts of the exam may give a hint as to cause (dentition, clubbing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is present in a Lab workup?

A

Chest x-ray
Sputum for Gram stain and culture (look for absence of epithelial cells)
o Blood cultures
o CBC with differential, procalcitonin
o Legionella and pneumococcal urinary antigens (no cough), PCR for virus,
atypical pathogens- foreign, travel, IMC, fungal
o ? Bronchoscopy
o ABG- hypoxia, inc acid/base imbalance
o In > 50% of cases where they look hard no organism is ever found, <10% with standard workup

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

• Decision to hospitalize “art of medicine”

A
o	Age > 65 years
o	Coexisting illness (alcoholism, COPD, diabetes)
o	Leucopenia, marked leukocytosis
o	Evidence of respiratory failure
o	Septic appearance
o	Lack of support at home

o ICU admission if:
 SBP < 90
 Multilobar disease, “double PNA” dec O@
 PAO2/FIO2< 250- ABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

• Prophylaxis

A

Pneumococcal vaccine
anyone with chronic cardiopulmonary disease, renal disease, asplenia, HIV, age > 65

both PCV13 and PPSV23 given sequentially to all adults aged ≥65 years and to adults of any age who have underlying conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

o Influenza vaccine

A

 Age > 6 months
 under 8 need two flu shots the first year vaccinated
 You cannot get the flu from the flu shot
if sick, likely from prev. encounter. Split into lego pieces cannot form together to form flu.
 Only major contraindication is allergy to chicken eggs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

• Lung abscess

A

Results from aspiration of oral contents
Alcoholics, IVDA, altered mental status (CVA)
Poor oral hygiene
Hematogenous spread

o	Sputum odor!
o	Gram stain shows mixed normal flora
o	Usually a polymicrobial infection
o	May require surgical drainage
o	Antibiotics needed to cover anaerobes and oral flora
Clindamycin, Flagyl plus cephalosporin
o	Treatment needs to be prolonged
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are factor that inc risk of Penicillin-resistant and drug-resistant pneumococci?

A

Age > 65 years
• β-Lactam therapy within the past 3 months
• Alcoholism
• IMC (or w/ steroids)
• comorbidities
• Exposure to a child in a daycare center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are factor that inc risk ofEnteric Gram-negative organisms?

A
  • nursing home
  • cardiopulmonary disease
  • comorbidities
  • Recent ABX therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are factor that inc risk P aeruginosa

A
  • bronchiectasis, lung structure
  • Corticosteroid (>10 mg prednisone/day)
  • Broad-spectrum ABX > 7 days in the past month
  • malnutrition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is organism and treatment for Outpatient CAP with No Cardiopulmonary Disease and No Modifying Factors

A
American/ATS
•	S pneumoniae
•	C pneumonia (alone or as mixed infection)
•	M pneumonia
•	H influenza
•	Viruses
•	Miscellaneous
o	Moraxella catarrhalis, Legionella spp, M tuberculosis, endemic fungi

Therapy
• Macrolide (azithromycin or clarithromycin) – OR –
• Doxycycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is organism and treatment for Outpatient CAP With Cardiopulmonary Disease and/or Modifying Factors

A
same 
enteric G- bacilli- not good
Therapy-cover resistace, assist PCN
•	Selected β-lactam (cefpodoxime, cefuroxime, high-dose ampicillin (tid), amoxicillin/clavulante)
- PLUS –

• Macrolide or doxycycline
- OR –
• Antipneumococcal quinolone alone qd (cardiac, tendon tears, c. diff)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is organism and treatment for Hospitalized Patients with CAP w/ pseudomonal risk?

A
Probable organisms
•	SCHM
•	Aerobic Gram-negative bacilli
•	Legionella spp
•	Respiratory viruses
o	S aureus, M catarrhalis,
 M tuberculosis, 
endemic fungi

Therapy
• Selected β-lactam with antipneumococcal activity (ceftriaxone, cefotaxime, ampicillin/sulbactam, high-dose ampicillin), IV
- PLUS –
• Macrolide (choose oral or IV) or doxycycline (choose oral or IV)

  • OR –
    • Antipneumococcal quinolone alone, IV
17
Q

What is organism and treatment for Hospitalized Patients with Severe CAP, Patients with no pseudomonal risk factors:

A
•	S pneumoniae (including PRSP)
•	Legionella spp
•	H inflluenzae
•	Enteric Gram-negative organisms
•	S aureus
•	M pneumoniae or C pneumoniae
•	Respiratory viruses
•	Miscellaneous
o	M tuberculosis, endemic fungi

Therapy
• Macrolide or antipneumococcal quinolone, IV
- PLUS –
• Selected β-lactam with antipneumococcal activity (ceftriaxone, cefotaxime, ampicillin/sulbactam)
DELAYS or wrong= death
shotgun approach

18
Q

What is organism and treatment for Hospitalized Patients with Severe CAP, Patients with no pseudomonal risk factors:
Patients with pseudomonal risk factors:

A
•	S pneumonia (including PRSP)
•	Legionella spp
•	H influenza
•	Enteric Gram-negative organisms
•	S aureus
•	M pneumoniae or C pneumoniae
•	Respiratory viruses
•	Miscellaneous
o	M tuberculosis, endemic fungi

Therapy
• Ciprofloxacin PLUS antipseudomonal, antipneumococcal β-lactam (imipenem, meropenem, cefepime, piperacillin/tazobactam)
- OR –
• Nonpseudomonal quinolone (levofloxacin, gatifloxacin, moxifloxacin) or macrolide
PLUS antipseudomonal, antipneumococcal β-lactam (imipenem, meropenem, cefepime, piperacillin/tazobactam) PLUS aminoglycoside

19
Q

Other types of PFTs available

A

Methacholine challenge
6 minute walk
Oxygen desaturation/titration study
Altitude study
Measurements of muscle strength (MVV, MIP, MEP)
Cardiopulmonary exercise test to determine the cause of dyspnea

20
Q

Hyoxemia

A
High altitude
V/Q < 1
Shunts- alveoli perfused but bronchi vessels cant get O2, obstructed so no air transfer
Diffusion limitation
Hypoventilation (elevated PaCO2)
21
Q

Restrictive Lung Disease

A

Gold standard – Low Total Lung Capacity (TLC)

Less than 80% predicted

22
Q

Restriction - parenchymal

A

lung tissue that results in a loss of parenchyma,
stiff (low compliance), and may result in abnormal gas exchange (hypoxemia) and eventually hypoventilation (high PaCO2)

Scarring post-infection, related to inhaled irritants (asbestos), or intrinsic process.

23
Q

Compliance Curve

A

Normal – deflection point, smooth up.

Stiff or flat – parenchymal or pleural or chest wall (pulmonary fibrosis, pleural thickening, edema, stiff chest wall), delation

High – poor lung tissue – floppy (emphysema)

24
Q

Do all patients with a low FVC (forced vital capacity) on spirometry have restrictive lung disease?

Do all patients with a low TLC (total lung capacity have restrictive disease?

A

Yes

No

25
Q

Gas Exchange (V/Q) perfusion

A

heterogeneity of V/Q in all lungs.
Normal lung V/Q = 1

Obstruction V/Q < 1

Pulmonary vascular disease V/Q > 1

26
Q

IPF Idiopathic pulmonary fibrosis

A

6th- 7th decade,
M>W,
smokers

S/S Gradual onset dyspnea, dry cough
Dry crackles on exam, interstitial changes on HRCT
Not due to other illness

27
Q

IPF treatment

A
Supportive care (oxygen, pulm rehab)
Anti-esoph reflux treatment
Pirfenidone (anti-fibrotic)
Nintedanib (TK inhibitor)
Lung transplant
28
Q

Sarcoid

A

Idiopathic illness of young adults

Non-caseating granulomas many organs

Blacks> whites

Pulmonary- restrictive disease or asymptomatic abnormal

CXR

Other Organs can be affected
Cardiac (sudden death)
Bone (always)
Liver (always but doesn’t cause illness)
Renal, including stones
Eyes
Skin (e  nodosum)
CNS
29
Q

Sarcoid

A

Almost always requires a biopsy

referred to pulmonary

Treatment (if any)
Steroids

30
Q

Extra-Parenchymal

A
Pectus excavatum
Kyphoscoliosis-progressive and severe, leading to impairment of lung function and restriction
Flail chest – acute
Pleural disease
Pleural effusions
Ankylosing spondylitis
31
Q

Obesity

A

Impairs lung excursion
Compresses diaphragms
Impairs inspiratory capacity
obesity-hypoventilation syndrome

32
Q

Abdominal Processes

A

Distended bowel /obstruction
Trauma
Peritonitis
Compartment syndrome

33
Q

Neuro-Muscular Diseases

A

ALS
Almost always progressive
Ascending paralysis
Progressive worsening of lung capacity – FVC followed

34
Q

Daiphragmatic Paralysis

A
Unilateral or bilateral
Trauma
Surgery
Idiopathic – maybe viral
Can resolve
Presents with dyspnea and/or recurrent atelectasis and pneumonias
35
Q

Work of Breathing

A

physical activity driven by the drive to breathe by nerves to the respiratory muscles (diaphragm, intercostals, accessory) overcoming elastic load (lung compliance) and resistive load (airways).

In normal lungs, resting work of breathing is 3% of energy expenditure; whereas, at maximum exercise it is 10%

stiff lungs or obstructive diseases, the work is much greater

36
Q

Dyspnea/Restriction

A

Primary symptom is dyspnea

Activation of stretch receptors from stiff lung leads to symptoms

stiff lung and work= drive to keep a normal PaO2 and PaCO2, the respiratory pattern is tachypnea,, small TV

37
Q

Control of Ventilation

Drives to breathe:

A

Chemosensors: (hypoxemia, CO2, pH) in brainstem and carotid bodies

Mechanoreceptors: lung tissue, stretch

O2/CO2 homeostasis